GFAP and encephalomyelitis: Previously, GFAP and MT3 have been linked to trauma, ischemia, and neurodegenerative diseases, including encephalomyelitis, multiple sclerosis, Parkinson’s disease, Alexander disease, Alzheimer’s disease, and amyotrophic lateral sclerosis.21